|
|
40
|
|
|
49712
|
|
|
APO-HYDROXYUREA 500MG CAP (APO/COL)
|
|
|
HYDROXYUREA
|
|
|
APO-HYDROXYUREA
|
|
|
100'S
|
|
|
C
|
|
|
93.70
|
|
|
0.94
|
|
|
500MG
|
|
|
CAPSULE
|
|
|
0
|
|
|
CAP
|
|
|
APO
|
|
|
APOTEX INC.
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
B
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|